Pfizer Ready For Medicare Formularies, CEO Says; Humana JV Begins
Executive Summary
Pfizer does not expect implementation of Medicare Rx formularies to have a significant impact on access to its products, CEO Hank McKinnell said during the company's Jan. 19 sales and earnings call
You may also be interested in...
Employers Wary Of Disease Management; Pfizer Takes Model To Employees
Insurers appear to be steering employers away from pharmaceutical industry disease management programs with the message that they are not cost effective
Employers Wary Of Disease Management; Pfizer Takes Model To Employees
Insurers appear to be steering employers away from pharmaceutical industry disease management programs with the message that they are not cost effective
USP Final Formulary Guide Adds PPI Class, But Has Few Other Changes
Proton pump inhibitors may be the only commercially significant group of drugs to gain "pharmacologic class" status in the revisions to U.S. Pharmacopeia's model guidelines for Medicare drug plans